Regeneron Pharmaceuticals (REGN) News Headlines

▮ More

Date

Headline

7/1/2019 10:25:39 AM Sanofi : EU Okays Libtayo For Advanced Cutaneous Squamous Cell Carcinoma

6/28/2019 7:11:07 AM Regeneron Pharma: CHMP Adopts Positive Opinion For Dupixent - Quick Facts

6/28/2019 7:01:29 AM Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent For Moderate-to-Severe Atopic Dermatitis In Adolescents

6/21/2019 1:20:10 AM Regeneron Pharma: REGN3500 Meets Primary Endpoint In Phase 2 Study

6/21/2019 1:00:40 AM Regeneron, Sanofi: Phase 2 Proof-of-concept Trial Evaluating IL-33 Antibody REGN3500 Met Primary Endpoint

6/14/2019 7:35:09 AM Regeneron Announces Positive Early-stage Data For REGN1979 - Quick Facts

6/14/2019 7:02:16 AM Regeneron Announces Positive Early-stage Data For REGN1979 In Patients With R/R B-cell Non-Hodgkin Lymphoma

5/24/2019 11:16:57 PM Biotech Stocks Facing FDA Decision In June 2019

5/16/2019 7:08:58 AM Regeneron Pharma, Sanofi Say Positive Updated Data For Libtayo To Be Shared At ASCO Annual Meeting

5/7/2019 9:21:59 AM Regeneron & Sanofi: Dupixent Approved For Severe Asthma Indication In EU

5/7/2019 9:06:57 AM Regeneron And Sanofi Announce That EC Approve New Indication For Dupixent In Asthma

5/7/2019 7:33:46 AM Regeneron Pharmaceuticals Q1 19 Earnings Conference Call At 8:30 AM ET

5/7/2019 6:37:34 AM Regeneron Pharmaceuticals Q1 adjusted earnings Miss Estimates

5/7/2019 6:32:20 AM Regeneron Q1 GAAP EPS $3.99 And Non-GAAP EPS $4.45

4/29/2019 12:52:49 AM Sanofi: FDA Approves Praluent To Prevent Heart Attack, Stroke, Unstable Angina

4/26/2019 3:15:22 AM Biotech Stocks Facing FDA Decision In May 2019

4/8/2019 7:21:56 AM Regeneron To Invest $800 Mln In Alnylam; To Jointly Develop RNAi Therapeutics

4/8/2019 7:01:41 AM Regeneron And Alnylam Collaborate To Discover, Develop And Commercialize New RNAi Therapeutics

3/26/2019 7:16:18 AM Biotech Stocks Facing FDA Decision In April

3/13/2019 7:01:16 AM Regeneron And Sanofi To Present New Praluent Data At ACC.19